doi:10.3969/j.issn.1673-8640.2020.10.020

Abstract

CLC Number:

R446.1

Figures/Tables 3

References 15

[1]	徐湘民,张新华,陈荔丽. 地中海贫血预防控制操作指南[M]. 北京:人民军医出版社,2011.
[2]	秦良谊. 我国β链异常血红蛋白发生率、基因频率和分布[J]. 医学研究通讯,2004,33(1):17-18.
[3]	李友琼,黄慧嫔,阳文辉,等. 广西地区血红蛋白New York的血液学和分子特征[J]. 中华血液学杂志,2013,34(8):696-699.
[4]	莫宗平,张玲,喻长顺,等. 异常血红蛋白81例基因分析[J]. 广东医学,2012,33(3):338-341.
[5]	冉健,任振敏,裴元元,等. 深圳地区9 569例妊娠期妇女血红蛋白电泳结果分析[J]. 检验医学与临床,2014,11(20):2801-2802.
[6]	温应方,林敏,刘桂荣,等. 广东梅州地区的异常血红蛋白的分子流行病学调查[J]. 重庆医科大学学报,2011,36(12):1496-1499.
[7]	马占忠,杨辉,林敏,等. 广东韶关地区异常血红蛋白的分子流行病学调查[J]. 实用检验医师杂志,2014,6(3):179-181.
[8]	李育敏,张水兰,阚丽娟,等. 罕见地中海贫血基因变异的分子特征与表型[J]. 检验医学,2019,34(7):613-616.
[9]	张强,范歆,何升,等. Hb New York病ARMS-PCR检测及临床表型分析[J]. 临床检验杂志,2014,32(9):706-707.
[10]	卢建,王继成,姚翠泽,等. 异常血红蛋白Hb New York的分子诊断及血液学特征分析[J]. 新医学,2018,49(6):421-424.
[11]	陈冬,李萍,葛艳芬,等. 异常HbK复合β地中海贫血家系及其风险胎儿的产前诊断[J]. 南方医科大学学报,2009,29(11):2343-2344.
[12]	吴教仁,林炳忠,陈钊. 血红蛋白E及血红蛋白E复合β地中海贫血的临床分析[J]. 临床血液学杂志,2004,17(4):204-206.
[13]	赵颖,商璇,熊符,等. 异常血红蛋白(Hb J-Bangkok)合并β地中海贫血的临床表型分析[J]. 中华医学遗传学杂志,2013,30(2):148-151.
[14]	郭浩,杜丽,唐斌,等. 脐血血红蛋白电泳在新生儿地中海贫血筛查中的应用[J]. 实用医学杂志,2014,30(12):1953-1955.
[15]	唐健,何建萍,罗胜军,等. 6例异常血红蛋白K(Hb K)的基因型分析[J]. 昆明医科大学学报, 2018,39(9):91-94.

分子特征	性别	例数	血液学参数
分子特征	性别	例数	Hb/（g/L）	MCV/fL	MCH/pg	HbA₂/%	Hb NewYork/%
单纯Hb NewYork杂合子	男	21	151.0±8.3	86.3±4.2	28.8±1.6	3.0±0.5	44.5±1.1
	女	36	119.0±14.2	86.0±7.2	28.5±3.2	3.0±0.2	43.8±2.2
Hb NewYork复合-α^3.7杂合缺失	男	1	153	81.0	25.8	3.2	39.9
Hb NewYork复合IVS-Ⅱ-81杂合突变	女	1	118	90.0	30.2	2.9	41.9

分子特征	性别	例数	血液学参数
分子特征	性别	例数	Hb/（g/L）	MCV/fL	MCH/pg	HbA₂/%	Hb NewYork/%
单纯Hb NewYork杂合子	男	21	151.0±8.3	86.3±4.2	28.8±1.6	3.0±0.5	44.5±1.1
	女	36	119.0±14.2	86.0±7.2	28.5±3.2	3.0±0.2	43.8±2.2
Hb NewYork复合-α^3.7杂合缺失	男	1	153	81.0	25.8	3.2	39.9
Hb NewYork复合IVS-Ⅱ-81杂合突变	女	1	118	90.0	30.2	2.9	41.9

新生儿Hb NewYork杂合子编号	性别	血液学参数
新生儿Hb NewYork杂合子编号	性别	HbA/%	HbF/%	Hb NewYork/%
1	男	6.8	89.1	4.1
2	男	9.4	86.4	4.2
3	男	9.6	85.1	5.2
4	男	7.5	87.2	5.3
5	男	6.3	89.2	4.5
合计		7.9±1.5	87.4±1.8	4.7±0.6

新生儿Hb NewYork杂合子编号	性别	血液学参数
新生儿Hb NewYork杂合子编号	性别	HbA/%	HbF/%	Hb NewYork/%
1	男	6.8	89.1	4.1
2	男	9.4	86.4	4.2
3	男	9.6	85.1	5.2
4	男	7.5	87.2	5.3
5	男	6.3	89.2	4.5
合计		7.9±1.5	87.4±1.8	4.7±0.6

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 3

References 15

Related Articles 15

Recommended Articles

Metrics

[1]	GAO Zikang, CHEN Jing. Construction of a nomogram prediction model for the prognosis of patients with depressive disorder based on the characteristics of peripheral blood lymphocyte subsets [J]. Laboratory Medicine, 2025, 40(12): 1146-1152.
[2]	WANG Tian, ZHANG Yun, BAI Yi, ZHAI Weibin, ZHAO Hai. Roles of PIV，SII and NPAR in the diagnosis of spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites [J]. Laboratory Medicine, 2025, 40(12): 1153-1158.
[3]	HUANG Ting, XU Yan, SHI Qingxing, PENG Ying. Roles of miR-944 and MARCH7 mRNA in prognosis assessment of non-small cell lung cancer patients [J]. Laboratory Medicine, 2025, 40(12): 1159-1164.
[4]	LI Minghong, MIN Cuili, GUO Qingbo, MA Lujuan. Predictive roles of serum 25（OH）D and SAA for the response to immunosuppressive therapy in autoimmune hepatitis [J]. Laboratory Medicine, 2025, 40(12): 1165-1170.
[5]	ZHEN Di, JIA Bin, MENG Xianyi. Roles of serum sPD-1 and sTWEAK levels in patients with ulcerative colitis in disease monitoring and prognosis assessment [J]. Laboratory Medicine, 2025, 40(12): 1171-1176.
[6]	ZHAO Yilin, XU Yan, YIN Hui. Roles of serum miR-145-5p，miR-200C-3p and miR-1290 in prognosis assessment of patients with papillary thyroid carcinoma [J]. Laboratory Medicine, 2025, 40(12): 1177-1182.
[7]	LI Song, XIANG Xu. Risk factors for poor prognosis in elderly patients with severe fever and thrombocytopenia syndrome and their clinical significance [J]. Laboratory Medicine, 2025, 40(12): 1183-1189.
[8]	CHANG Nan, WEI Yali, LU Qifeng, LI Tian, HOU Tingting, LI Yuan, ZHU Mengyu, SHEN Yajuan. A machine learning early warning model for acute promyelocytic leukemia based on blood cell analyzer parameters [J]. Laboratory Medicine, 2025, 40(12): 1190-1196.
[9]	. [J]. Laboratory Medicine, 2025, 40(12): 1197-1202.
[10]	. [J]. Laboratory Medicine, 2025, 40(12): 1216-1221.
[11]	. [J]. Laboratory Medicine, 2025, 40(12): 1222-1226.
[12]	BAO Wen. Application and prospect of microsatellite instability determination in tumor diagnosis and treatment [J]. Laboratory Medicine, 2025, 40(12): 1227-1231.
[13]	XIONG Ying, GUO Wei. From generic to personalized：the evolution and frontiers of indirect methods for establishing reference interval [J]. Laboratory Medicine, 2025, 40(11): 1035-1041.
[14]	CHEN Yanqin, FAN Lina, YANG Dagan. Six indirect method algorithms for establishing the reference range of serum cystatin C for adults in Hangzhou and consistency analysis [J]. Laboratory Medicine, 2025, 40(11): 1047-1052.
[15]	LIU Chunyan, NIU Shumin, DENG Zhaohui, LIANG Mengjie, ZHANG Xin. Establishing the reference ranges for AFP，CEA，CA72-4 and CA19-9 in Urumqi region by indirect method [J]. Laboratory Medicine, 2025, 40(11): 1053-1058.